KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+6.02%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$145M
AUM Growth
–
Cap. Flow
+$145M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
10
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$123M |
| 2 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$7.55M |
| 3 |
Arcturus Therapeutics
ARCT
|
$4.02M |
| 4 |
SQNM
SEQUENOM INC NEW
SQNM
|
$3.91M |
| 5 |
Genworth Financial
GNW
|
$3.65M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 9.61% |
| 2 | Financials | 2.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
| $123M | 84.26% | +2,504,101 | New | +$123M |
|
|
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $7.55M | 5.16% | +1,308,455 | New | +$7.55M |
|
|
3
Arcturus Therapeutics
ARCT
$462M
| $4.02M | 2.75% | +587,000 | New | +$4.02M |
|
|
SQNM
4
DELISTED
SEQUENOM INC NEW
SQNM
| $3.91M | 2.67% | +928,100 | New | +$3.91M |
|
|
5
Genworth Financial
GNW
$3.52B
| $3.65M | 2.5% | +320,000 | New | +$3.65M |
|
|
LUMO
6
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $935K | 0.64% | +47,437 | New | +$935K |
|
|
KERX
7
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $747K | 0.51% | +100,000 | New | +$747K |
|
|
ACHN
8
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $450K | 0.31% | +55,000 | New | +$450K |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $204K | 0.14% | +27,925 | New | +$204K |
|
|
ECTE
10
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $111K | 0.08% | +444,445 | New | +$111K |
|
|
VVUS
11
DELISTED
Vivus Inc
VVUS
| – | – | 0 | – | – |
|